1800 244 735

Helpline (02) 9874 9777

Coming soon from the HD World Congress: Oz Buzz!

This September, your HDBuzz editors Jeff Carroll and Ed Wild will be teaming up with Emmy award-winning broadcaster Charles Sabine to bring you ‘Oz Buzz’ – the hottest science news from the World Congress on Huntington’s Disease in Melbourne, Australia – September 11-14, 2011.

The World Congress on Huntington’s Disease

The World Congress on Huntington’s Disease is the biggest regular meeting of people with Huntington’s disease, people at risk, family members, friends, carers, scientists and health professionals.

It’s a unique opportunity for the global Huntington’s disease community to come together and for people to learn from each other.

For HD-affected people, it’s a great opportunity to hear directly about the latest progress towards treatments for HD, to meet scientists who are working on HD, and to find out what’s working, what’s not and what might be around the corner. Chat to your favorite researcher and thank them – or tell them to hurry up!

For scientists and care professionals, it’s a valuable time to get to know HD family members and hear about their lives. It is so motivating, for a scientist who may spend all day looking down a microscope, to meet the people his or her work is trying to help.

The World Congress is held every two years. This year’s is in Melbourne, Australia – at the Melbourne Convention and Exhibition Centre. It’s the first time the World Congress has been held outside Europe and America.

The Congress begins on Sunday 11th September 2011 and ends on Wednesday 14th September.

Registration is open via the World Congress website at http://worldcongress-hd2011.org/. Family members get a discounted registration price of 320 Australian dollars (about 240 US dollars, 240 Euros or 210 British pounds).

HDBuzz has seen a sneak preview of the Congress timetable and we’re really excited at the quality and diversity of speakers and poster presentations.

Our advice – beg, borrow or steal to get to Melbourne in September.

Announcing … Oz Buzz!

We’re excited to announce that your HDBuzz editors-in-chief, Jeff Carroll and Ed Wild, will be presenting a nightly feature at the World Congress – which we’re calling Oz Buzz.

Oz Buzz will bring you all the hottest science news of the World Congress, with the HDBuzz ethos: the latest research news – brought to you by scientists – in plain language – for the global HD community.

We’ll be joined by our friend, Emmy award-winning broadcaster and former NBC News anchor, Charles Sabine. Charles will be hosting the Oz Buzz feature, and making sure Jeff and Ed stay on track without lapsing into jargon and science-speak.

You might be familiar with the ‘triplet repeat’ of Charles, Ed and Jeff, from their popular ‘Evening News’ presentations at the 2009 World Congress in Vancouver and the 2010 Euro-HD Meeting in Prague. You can watch videos of those ‘Evening News’ slots online.

What’s new about Oz Buzz?

With Oz Buzz, we aim to build on the success of our previous ‘Evening News’ features, while unveiling a new format that will allow us to delve a bit deeper into the most exciting science from the Congress.

Of course, not everyone can make it to Melbourne. So we want to emphasize the truly global nature of the 2011 World Congress, by using internet and social media technology to connect with the hundreds of thousands of HD-affected people around the globe.

We don’t want to give away too much just yet – but look forward to:

    n

  • Twitter science updates from the Congress in real time

  • n

  • Live interviews, in plain language with the top scientists and clinicians

  • n

  • Online interactive text and video Q & A sessions

  • n

  • Real time video feeds of Oz Buzz

  • n

  • Special guests

  • n

Watch this space

Closer to September, we’ll post instructions for how you can interact with the World Congress via Oz Buzz.

In the meantime, to catch our live science updates from Melbourne, sign up to our Twitter feed by following HDBuzzFeed.

And don’t forget to head over to http://worldcongress-hd2011.org/, where you can check out the program and register to attend.

We hope to see you in Oz!

Share on facebook
Share on twitter
Share on pinterest
Share on email

Latest Research Articles

Updates from the EHDN Plenary Meeting 2020

Published date: 8 January, 2021

In September, the European Huntington’s Disease Network (EHDN) hosted a virtual webinar event which comprised presentations on some of the latest scientific research as well as clinical studies of Huntington’s disease (HD). Researchers, doctors, patients and other interested folks, tuned in for an afternoon of talks as well as question and answer sessions to learn ... Read more

Uncovering the dark side of DNA repair to design HD treatments

Published date: 22 December, 2020

A gene known as ‘MSH3’, which encodes a protein involved in fixing and maintaining our DNA, has become a hot topic in Huntington’s research since being implicated as a key driver of the disease by multiple genetic studies. In a recent publication, a team of scientists from the National University of Ireland, Galway, have provided ... Read more

Huntington Study Group (HSG) 2020 Annual Conference: HD in Focus – Day 2

Published date: 1 November, 2020

The second day of the HSG conference was another busy day of presentations from HD researchers and clinicians. The day kicked off with a talk from Vaccinex who gave us an overview of their work on the SIGNAL clinical trial. Unfortunately, pepinemab, the medicine tested in this trial, did not influence HD symptoms and the ... Read more

Huntington Study Group (HSG) 2020 Annual Conference: HD in Focus – Day 1

Published date: 30 October, 2020

The Huntington Study Group (HSG) is a clinical research network focused exclusively on HD. Yesterday the HSG annual conference began with a schedule jam-packed with virtual talks from researchers, clinicians and different companies who are all working towards finding new medicines for HD. The day encompassed many interesting presentations which covered a lot of the ... Read more

Treatment for neurological disorder could be repurposed for Huntington’s disease patients

Published date: 22 October, 2020

While developing a drug called branaplam for patients with SMA, the pharmaceutical company Novartis discovered that it could hold promise for people with HD. The FDA has granted a special status called Orphan Drug Designation to branaplam. An existing drug…for huntingtin lowering? The pharmaceutical company Novartis has announced that the U.S. Food and Drug Administration ... Read more

Sad news from the SIGNAL study: pepinemab does not influence HD symptoms

Published date: 23 September, 2020

The SIGNAL clinical trial was designed to test a drug called pepinemab in people with early Huntington’s disease. The key results of that trial were recently announced, and unfortunately, pepinemab did not slow or improve HD symptoms as hoped. What was the SIGNAL trial, and who participated? The SIGNAL trial was launched in 2015 by ... Read more